Organisation in HEIDELBERG
EUROPEAN VACCINE INITIATIVE EWIV
In 0 Bekanntmachungen genannt, seit 1. Januar 2012, aber in keiner als Auftragnehmer eines Zuschlags.
Fördermittel
Kohesio und Finanztransparenzsystem der EU, so gezählt.
19 Förderungen, zusammen 8,3 Mio. €.
| Quelle | Balken | Betrag | Förderungen |
|---|---|---|---|
| EU-Haushalt (Finanztransparenzsystem) | 8,3 Mio. €19 | 19 |
| Jahr | Programm | Projekt | Betrag und Beleg |
|---|---|---|---|
| 2021 | EU Budget - European CommissionRTD - Directorate-General for Research and Innovation825904 - SENET - STRENGTHENING INTERNATIONAL R&I COOPERATIONS BETWEEN CHINA AND THE EU | 825904 - SENET - STRENGTHENING INTERNATIONAL R&I COOPERATIONS BETWEEN CHINA AND THE EU | 0 €Beleg: Förderung 2021/JAG.246525.3, Empfänger 79098Mittelbindung |
| 2021 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101037867 - VACCELERATE - VACCELERATE - EUROPEAN CORONA VACCINE TRIAL ACCELERATOR PLATFORM | 101037867 - VACCELERATE - VACCELERATE - EUROPEAN CORONA VACCINE TRIAL ACCELERATOR PLATFORM | 751.029 €Beleg: Förderung 2021/JAG.755194.1, Empfänger 50151Mittelbindung |
| 2021 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101037867 - VACCELERATE - VACCELERATE - EUROPEAN CORONA VACCINE TRIAL ACCELERATOR PLATFORM | 101037867 - VACCELERATE - VACCELERATE - EUROPEAN CORONA VACCINE TRIAL ACCELERATOR PLATFORM | 1.052.528 €Beleg: Förderung 2021/JAG.755194.2, Empfänger 50078Mittelbindung |
| 2021 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101037867 - VACCELERATE - VACCELERATE - EUROPEAN CORONA VACCINE TRIAL ACCELERATOR PLATFORM | 101037867 - VACCELERATE - VACCELERATE - EUROPEAN CORONA VACCINE TRIAL ACCELERATOR PLATFORM | 551.825 €Beleg: Förderung 2021/JAG.755194.3, Empfänger 50259Mittelbindung |
| 2020 | EU Budget - European CommissionRTD - Directorate-General for Research and Innovation730964 - TRANSVAC2 - EUROPEAN VACCINE RESEARCH AND DEVELOPMENT INFRASTRUCTURE | 730964 - TRANSVAC2 - EUROPEAN VACCINE RESEARCH AND DEVELOPMENT INFRASTRUCTURE | 355.837 €Beleg: Förderung 2020/JAG.122435.2, Empfänger 95005Mittelbindung |
| 2020 | EU Budget - European CommissionRTD - Directorate-General for Research and Innovation825904 - SENET - STRENGTHENING INTERNATIONAL R&I COOPERATIONS BETWEEN CHINA AND THE EU | 825904 - SENET - STRENGTHENING INTERNATIONAL R&I COOPERATIONS BETWEEN CHINA AND THE EU | 30.629 €Beleg: Förderung 2020/JAG.246525.2, Empfänger 93919Mittelbindung |
| 2020 | EU Budget - European CommissionRTD - Directorate-General for Research and Innovation951668 - TRANSVAC-DS - DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE | 951668 - TRANSVAC-DS - DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE | 791.219 €Beleg: Förderung 2020/JAG.619061.1, Empfänger 76311Mittelbindung |
| 2020 | EU Budget - European CommissionRTD - Directorate-General for Research and Innovation951668 - TRANSVAC-DS - DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE | 951668 - TRANSVAC-DS - DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE | 197.805 €Beleg: Förderung 2020/JAG.619061.2, Empfänger 76312Mittelbindung |
| 2019 | EU Budget - European CommissionRTD - Directorate-General for Research and Innovation815568 - SHIGETECVAX - EARLY CLINICAL DEVELOPMENT OF A LIVE, ATTENUATED COMBINATION VACCINE AGAINST SHIGELLA AND ETEC DIARRHOEA | 815568 - SHIGETECVAX - EARLY CLINICAL DEVELOPMENT OF A LIVE, ATTENUATED COMBINATION VACCINE AGAINST SHIGELLA AND ETEC DIARRHOEA | 359.759 €Beleg: Förderung 2019/JAG.346827.1, Empfänger 11784Mittelbindung |
| 2018 | EU Budget - European CommissionRTD - Directorate-General for Research and Innovation825904 - SENET - STRENGTHENING INTERNATIONAL R&I COOPERATIONS BETWEEN CHINA AND THE EU | 825904 - SENET - STRENGTHENING INTERNATIONAL R&I COOPERATIONS BETWEEN CHINA AND THE EU | 137.375 €Beleg: Förderung 2018/JAG.246525.1, Empfänger 22254Mittelbindung |
| 2017 | EU Budget - European CommissionRTD - Directorate-General for Research and Innovation730964 - TRANSVAC2 - EUROPEAN VACCINE RESEARCH AND DEVELOPMENT INFRASTRUCTURE | 730964 - TRANSVAC2 - EUROPEAN VACCINE RESEARCH AND DEVELOPMENT INFRASTRUCTURE | 1.254.149 €Beleg: Förderung 2017/JAG.122435.1, Empfänger 2783Mittelbindung |
| 2016 | EU Budget - European CommissionRTD - Directorate-General for Research and Innovation732432 - ZIKAVAX - FAST TRACK DEVELOPMENT OF A ZIKA VACCINE BASED ON MEASLES VECTOR | 732432 - ZIKAVAX - FAST TRACK DEVELOPMENT OF A ZIKA VACCINE BASED ON MEASLES VECTOR | 27.407 €Beleg: Förderung 2016/JAG.83075.1, Empfänger 38464Mittelbindung |
| 2016 | EU Budget - European CommissionRTD - Directorate-General for Research and Innovation732432 - ZIKAVAX - FAST TRACK DEVELOPMENT OF A ZIKA VACCINE BASED ON MEASLES VECTOR | 732432 - ZIKAVAX - FAST TRACK DEVELOPMENT OF A ZIKA VACCINE BASED ON MEASLES VECTOR | 646.561 €Beleg: Förderung 2016/JAG.83075.2, Empfänger 5310Mittelbindung |
| 2013 | EU Budget - European CommissionRTD - Directorate-General for Research and InnovationPLACMALVAC | PLACMALVAC | 435.297 €Beleg: Förderung 2013/CPM.304815-963801.1, Empfänger 35125Mittelbindung |
| 2013 | EU Budget - European CommissionRTD - Directorate-General for Research and InnovationBELLEROPHON | BELLEROPHON | 0 €Beleg: Förderung 2013/CPM.601783-1036401.1, Empfänger 35127Mittelbindung |
| 2013 | EU Budget - European CommissionRTD - Directorate-General for Research and InnovationBELLEROPHON | BELLEROPHON | 0 €Beleg: Förderung 2013/CPM.601783-1036401.2, Empfänger 35128Mittelbindung |
| 2013 | EU Budget - European CommissionRTD - Directorate-General for Research and InnovationIPROVE | IPROVE | 78.067 €Beleg: Förderung 2013/CPM.602167-1172131.1, Empfänger 35126Mittelbindung |
| 2013 | EU Budget - European CommissionRTD - Directorate-General for Research and InnovationEDUFLUVAC | EDUFLUVAC | 930.000 €Beleg: Förderung 2013/CPM.602640-1171871.1, Empfänger 35124Mittelbindung |
| 2012 | EU Budget - European CommissionRTD - Directorate-General for Research and InnovationA Multi-Stage Malaria Vaccine | A Multi-Stage Malaria Vaccine | 700.000 €Beleg: Förderung 2012/CPM.305282-870711.1, Empfänger 29355Mittelbindung |
Angaben aus den Bekanntmachungen
0 Nennungen seit 1. Januar 2012, zuletzt am 1. Januar 2012, dieser Organisation zugeordnet. Wie wir zuordnen
- Anschrift
- VOSSSTRASSE 2 GEB 4040, 69115 HEIDELBERG
- USt-IdNr.
- DE815127939
- Schreibweisen
- EUROPEAN VACCINE INITIATIVE EWIV